Real-world outcomes following ibrutinib dose reduction in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
Shadman M, Salkar M, Srivastava B, Karve S, Emond B, Gogna P, Manceur AM, Lafeuille MH, Rava A, Sun H, Howarth A, Tomicki S, Agatep B, Jones B, Franceschini E, Saifan C, Bacchus S, Roeker L, Stephens DM.
Shadman M, et al. Among authors: sun h.
Leuk Lymphoma. 2025 Jan;66(1):44-53. doi: 10.1080/10428194.2024.2402814. Epub 2024 Oct 1.
Leuk Lymphoma. 2025.
PMID: 39352001